Skip to main content

Recombinant Human BACE1 Protein (Active) is a Human Fragment protein, in the 46 to 457 aa range, expressed in HEK 293, with >=95% purity and <= 0.005 EU/µg endotoxin level.

Be the first to review this product! Submit a review

Images

Biological Activity - Recombinant Human BACE1 Protein (Active) (AB290084), expandable thumbnail
  • SDS-PAGE - Recombinant Human BACE1 Protein (Active) (AB290084), expandable thumbnail

Key facts

Purity
>=95% SDS-PAGE
Endotoxin level
<= 0.005 EU/µg
Expression system
HEK 293 cells
Tags
Tag free
Biologically active
Yes

Amino acid sequence

E T D E E P E E P G R R G S F V E M V D N L R G K S G Q G Y Y V E M T V G S P P Q T L N I L V D T G S S N F A V G A A P H P F L H R Y Y Q R Q L S S T Y R D L R K G V Y V P Y T Q G K W E G E L G T D L V S I P H G P N V T V R A N I A A I T E S D K F F I N G S N W E G I L G L A Y A E I A R P D D S L E P F F D S L V K Q T H V P N L F S L Q L C G A G F P L N Q S E V L A S V G G S M I I G G I D H S L Y T G S L W Y T P I R R E W Y Y E V I I V R V E I N G Q D L K M D C K E Y N Y D K S I V D S G T T N L R L P K K V F E A A V K S I K A A S S T E K F P D G F W L G E Q L V C W Q A G T T P W N I F P V I S L Y L M G E V T N Q S F R I T I L P Q Q Y L R P V E D V A T S Q D D C Y K F A I S Q S S T G T V M G A V I M E G F Y V V F D R A R K R I G F A V S A C H V H D E F R T A A V E G P F V T L D M E D C G Y N I P Q T D E S T L M T

Target data

Function

Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase (PubMed:10656250, PubMed:10677483, PubMed:20354142). Cleaves CHL1 (By similarity).

Alternative names

Recommended products

Recombinant Human BACE1 Protein (Active) is a Human Fragment protein, in the 46 to 457 aa range, expressed in HEK 293, with >=95% purity and <= 0.005 EU/µg endotoxin level.

Key facts

Purity
>=95% SDS-PAGE
Endotoxin level
<= 0.005 EU/µg
Expression system
HEK 293 cells
Biological activity
Fully biologically active determined by its ability to cleave fluorogenic peptide substrate MCA-SEVNLDAEFR-Lys(DNP)-RR-NH2.
Specific activity is ≥ 4.2 pmol/min/ug.
Accession
P56817-1
Animal free
No
Species
Human
Concentration
Loading...
Storage buffer

pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic

Sequence info

Amino acid sequence

E T D E E P E E P G R R G S F V E M V D N L R G K S G Q G Y Y V E M T V G S P P Q T L N I L V D T G S S N F A V G A A P H P F L H R Y Y Q R Q L S S T Y R D L R K G V Y V P Y T Q G K W E G E L G T D L V S I P H G P N V T V R A N I A A I T E S D K F F I N G S N W E G I L G L A Y A E I A R P D D S L E P F F D S L V K Q T H V P N L F S L Q L C G A G F P L N Q S E V L A S V G G S M I I G G I D H S L Y T G S L W Y T P I R R E W Y Y E V I I V R V E I N G Q D L K M D C K E Y N Y D K S I V D S G T T N L R L P K K V F E A A V K S I K A A S S T E K F P D G F W L G E Q L V C W Q A G T T P W N I F P V I S L Y L M G E V T N Q S F R I T I L P Q Q Y L R P V E D V A T S Q D D C Y K F A I S Q S S T G T V M G A V I M E G F Y V V F D R A R K R I G F A V S A C H V H D E F R T A A V E G P F V T L D M E D C G Y N I P Q T D E S T L M T
Accession
P56817
Protein length
Fragment
Amino acids
46 to 457
Nature
Recombinant

Specifications

Form
Liquid

General info

Function

Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase (PubMed:10656250, PubMed:10677483, PubMed:20354142). Cleaves CHL1 (By similarity).

Sequence similarities

Belongs to the peptidase A1 family.

Post-translational modifications

N-Glycosylated (PubMed:11083922, PubMed:17425515). Addition of a bisecting N-acetylglucosamine by MGAT3 blocks lysosomal targeting, further degradation and is required for maintaining stability under stress conditions (By similarity).

Subcellular localisation
Endosome, Lysosome, Late endosome, Early endosome, Recycling endosome

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C

This product is an active protein and may elicit a biological response in vivo, handle with caution.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

BACE1 also known as beta-site APP cleaving enzyme 1 or beta-secretase plays an important role in the cleavage of amyloid precursor protein (APP). This cleavage results in the production of amyloid-beta peptides which are associated with Alzheimer's disease. BACE1 is a membrane-bound aspartic protease and has a molecular weight of approximately 50100 Da. The enzyme expresses mostly in the brain's neurons and some secretory tissues.

Biological function summary

BACE1 initiates the amyloidogenic pathway of APP processing which involves amyloid-beta generation. BACE1 doesn't function alone but acts as part of a complex that aids in protein substrate recognition and processing. Its activity contributes to physiological processes like myelination and axonal guidance indicating its importance beyond amyloid production.

Pathways

BACE1 is integral to the amyloidogenic pathway which is important in Alzheimer's disease development. It interacts with proteins such as presenilin 1 a part of the gamma-secretase complex that further processes the amyloid-beta precursor. Furthermore BACE1 links to synaptic functions and neural signaling pathways highlighting its multifaceted roles.

Associated diseases and disorders

BACE1 holds significance in Alzheimer's disease due to its role in amyloid-beta peptide production. This connection has led to the development of BACE1 inhibitors as potential therapeutic agents. Additionally BACE1’s involvement in other neural functions ties it to cognitive impairments. It also relates to APP through its function in Alzheimer's suggesting targeted strategies for treatment could involve modulating BACE1 activity.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Biological Activity - Recombinant Human BACE1 Protein (Active) (ab290084), expandable thumbnail

    Biological Activity - Recombinant Human BACE1 Protein (Active) (ab290084)

    Fully biologically active determined by its ability to cleave fluorogenic peptide substrate MCA-SEVNLDAEFR-Lys(DNP)-RR-NH2. Specific activity is ≥ 4.2 pmol/min/ug.

  • SDS-PAGE - Recombinant Human BACE1 Protein (Active) (ab290084), expandable thumbnail

    SDS-PAGE - Recombinant Human BACE1 Protein (Active) (ab290084)

    SDS-PAGE analysis of ab290084

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com